U.S. flag

An official website of the United States government

NM_001048174.2(MUTYH):c.1400G>A (p.Arg467His) AND not specified

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Nov 27, 2019
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000236240.10

Allele description [Variation Report for NM_001048174.2(MUTYH):c.1400G>A (p.Arg467His)]

NM_001048174.2(MUTYH):c.1400G>A (p.Arg467His)

Gene:
MUTYH:mutY DNA glycosylase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p34.1
Genomic location:
Preferred name:
NM_001048174.2(MUTYH):c.1400G>A (p.Arg467His)
HGVS:
  • NC_000001.11:g.45330550C>T
  • NG_008189.1:g.14921G>A
  • NM_001048171.2:c.1400G>A
  • NM_001048172.2:c.1403G>A
  • NM_001048173.2:c.1400G>A
  • NM_001048174.2:c.1400G>AMANE SELECT
  • NM_001128425.2:c.1484G>A
  • NM_001293190.2:c.1445G>A
  • NM_001293191.2:c.1433G>A
  • NM_001293192.2:c.1124G>A
  • NM_001293195.2:c.1400G>A
  • NM_001293196.2:c.1124G>A
  • NM_001350650.2:c.1055G>A
  • NM_001350651.2:c.1055G>A
  • NM_012222.3:c.1475G>A
  • NP_001041636.1:p.Arg481His
  • NP_001041636.2:p.Arg467His
  • NP_001041637.1:p.Arg468His
  • NP_001041638.1:p.Arg467His
  • NP_001041639.1:p.Arg467His
  • NP_001121897.1:p.Arg495His
  • NP_001121897.1:p.Arg495His
  • NP_001280119.1:p.Arg482His
  • NP_001280120.1:p.Arg478His
  • NP_001280121.1:p.Arg375His
  • NP_001280124.1:p.Arg467His
  • NP_001280125.1:p.Arg375His
  • NP_001337579.1:p.Arg352His
  • NP_001337580.1:p.Arg352His
  • NP_036354.1:p.Arg492His
  • LRG_220t1:c.1484G>A
  • LRG_220:g.14921G>A
  • LRG_220p1:p.Arg495His
  • NC_000001.10:g.45796222C>T
  • NM_001048171.1:c.1442G>A
  • NM_001128425.1:c.1484G>A
  • NR_146882.2:n.1628G>A
  • NR_146883.2:n.1477G>A
  • p.R495H
Protein change:
R352H
Links:
dbSNP: rs144111588
NCBI 1000 Genomes Browser:
rs144111588
Molecular consequence:
  • NM_001048171.2:c.1400G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001048172.2:c.1403G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001048173.2:c.1400G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001048174.2:c.1400G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001128425.2:c.1484G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293190.2:c.1445G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293191.2:c.1433G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293192.2:c.1124G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293195.2:c.1400G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293196.2:c.1124G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001350650.2:c.1055G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001350651.2:c.1055G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_012222.3:c.1475G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_146882.2:n.1628G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_146883.2:n.1477G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000917799Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Nov 24, 2017)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link,

SCV002067820Genetic Services Laboratory, University of Chicago
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Nov 27, 2019)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Functional Evaluation of Nine Missense-Type Variants of the Human DNA Glycosylase Enzyme MUTYH in the Japanese Population.

Shinmura K, Kato H, Goto M, Yamada H, Tao H, Nakamura S, Sugimura H.

Hum Mutat. 2016 Apr;37(4):350-3. doi: 10.1002/humu.22949. Epub 2016 Jan 8.

PubMed [citation]
PMID:
26694661

Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort.

Ring KL, Bruegl AS, Allen BA, Elkin EP, Singh N, Hartman AR, Daniels MS, Broaddus RR.

Mod Pathol. 2016 Nov;29(11):1381-1389. doi: 10.1038/modpathol.2016.135. Epub 2016 Jul 22.

PubMed [citation]
PMID:
27443514
PMCID:
PMC5541389
See all PubMed Citations (3)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000917799.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

Variant summary: The MUTYH c.1484G>A (p.Arg495His) variant involves the alteration of a non-conserved nucleotide. 2/4 in silico tools predict a benign outcome for this variant (SNPsandGO not captured due to low reliability index). This variant was found in 9/267106 control chromosomes at a frequency of 0.0000337, which does not exceed the estimated maximal expected allele frequency of a pathogenic MUTYH variant (0.0055902). The variant has been reported in Lynch Syndrome patients in the literature, one in the tumor of a patient who carried a likely pathogenic MSH2 germline variant, as well as in the germline of a patient carrying a pathogenic MSH6 variant (Vargas-Parra_2017, Ring_2016). However, due to the predominantly recessive mode of inheritance attributed to variants in MUTYH, the possibility of incidental carrier status for a pathogenic variant cannot be excluded. The DNA glycosylase activity and ability to suppress mutations caused by 8-hydroxyguanine, an oxidized form of guanine, were examined for the nine variants of type 2 MUTYH, a nuclear form of the enzyme, by DNA cleavage activity assay and supF forward mutation assay, respectively. The variant was similar to WT in DNA glycosylase activity and mutation frequency of the supF gene. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as uncertain significance. Taken together, this variant is classified as VUS.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Genetic Services Laboratory, University of Chicago, SCV002067820.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024